Overview
The Lipid Research Division is a division of the American Society for Biochemistry and Molecular Biology. The LRD represents lipid research scientists of the society and addresses concerns that include, but are not limited to, national and international visibility, representation at the annual meeting and on scientific advisory panels, and increased funding for lipid research. Additionally, the LRD serves as a platform within the ASBMB to highlight progress in lipid research and to foster communication among lipid researchers and between lipid researchers and the broader ASBMB membership.
We invite all lipid researchers to join the division. ASBMB membership is required.
ASBMB members: Edit the About Me section of your member profile and check the "Join the Lipid Research Division" box.
Activities
- Provides input to the ASBMB Meetings Committee relating to symposia, themes and sessions at the society's annual meeting.
- Provides a calendar of lipid-related meetings, a job board and links to resources for lipid researchers.
- Presents the Walter Shaw Young Investigator Award in Lipid Research, which the division established, at the society's annual meeting.
- Works closely with National Institutes of Health scientific review officers to increase representation of lipid researchers on appropriate study sections.
- Hosts monthly webinars that feature and attract lipid researchers from around the world.
- Publishes the "Lipid News" column in ASBMB Today and maintains an active presence on Facebook and Twitter.
- Collaborates with the Europe-based Lipid Maps organization to publish "Lipid Trends."
- Publicizes lipid research articles from the Journal of Lipid Research and the Journal of Biological Chemistry.
Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Highlights
